R&D Center-AR&D-Executive 3
PeopleStrong
Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Job summary
Sekhmet Pharmaventures Optimus Drugs (P) Ltd in India seeks an Executive 3 for R&D with 3–5 years of hands-on experience in HPLC, GC and physicochemical analyses. The role covers method development, validation and meticulous documentation in line with USP/EP/IP guidelines.
The successful candidate will work on LC-MS/GC-MS methods and support routine analyses within the ODPL AR&D Common framework, for a replacement position ending 15 Sep 2026.
Qualifications
- HPLC and GC analysis experience with method development and validations.
- Familiar with USP/EP/IP pharmacopeia guidelines and good documentation practices.
Responsibilities
- Perform HPLC, GC and LC-MS/GC-MS analyses including method development and validation.
- Ensure documentation quality and regulatory compliance in analytical workflows.
Skills
Education
Job description
- Sekhmet Pharmaventures>Optimus Drugs (P) Ltd>ODPL-R&D>R&D>A R & D>ODPL AR&D Common>2800801904
End Date 15 Sep 2026
Required Experience 3 - 5 years
Basic Section
Basic Section
No. Of Openings 1
Grade L6F
Designation Executive 3
Campus/Non Campus Non Campus
Employment Type Full Time
Requisition Type Replacement
Median 0 - 0
Comp off OT Applicability Comp off & Overtime
TAT 30
Confidential No
Closing Date 15 Sep 2026
Organisational
Organisational
HPLC-MS HPLC
Post Graduate
MSc
Hands on Exp in HPLC , GC and Physicochemical analysis (UV,IR,SOR,TLC Potentiometric titration including mentod development routine analysis & menthod validations along with good documentation practices
Hands on Exp in LC-Ms/GC-Ms including method develpoment, method validations and identification of unknown peaks along with good documentation practices.
Aware of regulatory guidelines, including USP/EP/IP Pharmacopeia's
Job Description
Sekhmet Pharmaventures>Optimus Drugs (P) Ltd>ODPL-R&D>R&D>A R & D>ODPL AR&D Common>2800801904
'/%3e%3cpath%20d='M101.744%2012.4726L102.894%2016.1947L99.0021%2013.2201L101.744%2012.4726ZM105.3%208.40937H100.488L99.0026%203.59473L97.5116%208.41047L92.7%208.40385L96.5965%2011.3834L95.1055%2016.1942L99.0021%2013.2196L101.408%2011.3834L105.3%208.40992V8.40937Z'%20fill='white'/%3e%3cdefs%3e%3clinearGradient%20id='paint0_linear_5593_1381'%20x1='90'%20y1='9.44471'%20x2='99'%20y2='9.44471'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20stop-color='%2300AD70'/%3e%3cstop%20offset='0.998594'%20stop-color='%2300B67A'/%3e%3cstop%20offset='1'%20stop-color='%23DCDCE6'/%3e%3c/linearGradient%3e%3c/defs%3e%3c/svg%3e){kind=small}
